They are usually sporadic, but sometimes familial. Using five families, we mapped the locus, VMGLOM, to chromosome 1p21-p22. In order to refine this locus, spanning 4-6 Mbp, we then studied seven additional families. They exhibited linkage to VMGLOM and the combined lod score for all 12 families was 18.41 at θ = 0.0 for marker D1S188. We found a distinct haplotype shared by seven families, comprising seven alleles which are rare in the general population (P < 0.01). This indicates that the haplotype is identical by descent in all seven families, and hence the locus can be refined by inferring ancestral crossovers. Using this approach, we position the causative gene between two markers on the same non-chimeric YAC of 1.48 Mbp, a feasible size for positional cloning. As there is no known gene involved in vasculogenesis and/or angiogenesis in this YAC, the identification of the causative gene is likely to reveal a novel regulator or vascular development. European Journal of Human Genetics (2001) 9, 34-38.
Introduction
Vascular malformations are localised errors of morphogenesis. 1 They are classified by the histologic appearance of the anomalous channels as either arterial, capillary, lymphatic, venous or combined malformations. 2 Vascular lesions are usually cutaneous and often disfiguring. Functional and even life-threatening problems can occur if these anomalies involve deeper structures or viscera. Venous malformations (VMs) are the most common in referral centres. They appear as bluish cutaneous lesions that are localised, either small or extensive. 1 To identify genes involved in venous morphogenesis, we studied families with inherited cutaneous venous malformations (OMIM No 600195), and found the first genetic locus on chromosome 9p21. 3 Subsequently, we identified the causative activating R849W mutation in TIE2/TEK, a receptor tyrosine-kinase specifically expressed in endothelial cells. 4 In addition to this locus, we discovered a second 4-6 cM locus on chromosome 1p21-p22 that is linked to venous malformations in five families (VMGLOM, OMIM No 138000). 5 Although the cutaneous lesions in these families clinically looked very similar to the 9p-linked VMs, histologic analysis of the lesions revealed the presence of 'glomus cells' around the lumens of the distorted vessels, hence the traditional histopathologic name 'glomangioma'. The causative gene is unknown and we are using positional cloning for its identification.
In order to refine the locus, we here report seven additional families with venous anomalies, show linkage to the VMGLOM locus and reveal the existence of a founder effect for some of the families, thereby refining the locus to the size of a single YAC.
Material and methods
The pedigrees of the seven new families with venous malformations with glomus cells are shown in Figure 1 . Each participant gave informed consent, as approved by the ethics committee of the medical faculty of the Université catholique de Louvain, Brussels, Belgium. Clinical history was taken and physical examination was performed on all family members participating in the study. Venous blood samples were drawn and DNA was extracted from the buffy coats (Qiagen QIAamp DNA Blood Mini Kit, Westburg, Leusden, The Netherlands). Histological characterisation was done on lesions excised from individuals in all families except family A1.
Genotyping of individuals was performed, as described elsewhere. 3 We used microsatellite markers located in the , giving a shorter PCR product. We also used novel CA repeat microsatellites that had been isolated in our laboratory as part of the construction of a physical map for the region (33CA1, 50CA1, 69CA1 and 75CA1). 6 Calculations were performed using the MLINK program of the LINKAGE package, 7 with parameters as described. 5 Phenocopies were not allowed and three penetrance classes were defined on the basis of Iqbal et al 8 ( Table 1 ).
In order to detect putative haplotype sharing, three affected individuals from each family (except for families Ba and A1, in which there are only two affected individuals) were genotyped for every available microsatellite marker in the VMGLOM locus ( Figure 2 ). The precise order of the markers was known by construction of the physical map of the locus. 6 The radioactive PCR products for each marker were resolved on a separate polyacrylamide gel to allow consistent scoring of the alleles across the families. Absolute sizes of the alleles were determined by running a pUC18 plasmid sequencing reaction on the same gel. As an additional control for the sizes of the alleles, PCR reactions from CEPH reference individuals (Nos 88415, 134702, 133101 and 133102, http://www.cephb.fr/cephdb/) were also included.
To estimate the frequencies of the shared alleles and haplotypes in the general population, 16 triplets (father, mother, child), belonging to the genetically heterogeneous Belgian population, were also genotyped. The frequencies of the shared alleles from the first and second haplotypes were calculated in the affected families and in our control dataset, comprising 64 haplotypes. Statistical significance of the frequency bias was assessed using the uncorrected chi-square test of independence. In order to retrieve from databases genomic sequences in the VMGLOM candidate region, the sequences of the markers Marker alleles with a probable ancestral mutation differ from shared haplotype: white background; n/N: number of the shared allele on total number of alleles; fam: families linked to VMGLOM; con: control individuals from the Belgian population. P: P-value for the uncorrected chi-square test in a 2 ϫ 2 table; *: significant P-value (P < 0.01).
Haplotype sharing in the VMGLOM locus y A Irrthum et al 36 redundant GenBank database using the NCBI blast tool, and to a database of EST contigs at the Swiss EMBnet server (http:/ www.ch.embnet.org/software/aBLAST.html).
Results
Physical examination of the patients from the families with venous malformations with glomus cells revealed that the locations, number per individual and histological appearance of the lesions were similar to those documented in the five families initially reported. 5 The number of affected males and females in the 12 families was 35 and 40, respectively, and 59% (26/44) of children of an affected parent had the disorder. Examination of the seven new pedigrees revealed that the condition skipped a generation twice (individuals Del5 and Bln104, Figure 1) . The autosomal dominant pattern of inheritance with high penetrance and the absence of sex bias are consistent with our previous data. 5 None of the seven new families formally excluded linkage to the VMGLOM locus. Lod scores for marker D1S188 are given for different recombination fractions in Table 1 . Family Lml showed strong linkage to the VMGLOM locus (lod score 4.05 for marker D1S2804). Families Sch, Bln, Del, Ad and Ba also showed evidence for linkage in the locus, with highest lod scores (at θ = 0.0) of 1.69 for marker D1S2776 (family Sch), 0.75 for marker D1S188 (family Bln), 0.56 for marker D1S188 (family Del), 0.56 for marker D1S2776 (family Ad), and 0.52 for marker D1S2776 (family Ba). Family A1 gave slightly negative lod scores (-0.18 for marker D1S188). The maximum combined lod score for the seven new families was 5.99 (θ = 0.0) for marker D1S188, and for all 12 families it was 18.41 (θ = 0.0), with no obvious evidence for locus heterogeneity. However, four young unaffected recombinants were observed (Lml223, A112, Sch1020 and Bln1070, aged 14 years, 10 years, 2 years and 1 year, respectively).
Haplotypic analysis of the seven families defined new obligatory recombinations in VMGLOM between markers AFMB337XE1 and D1S188 (affected individual Lml22) on the telomeric end of VMGLOM and between markers D1S236 and D1S2779 (affected individuals Sch3 and Bln100, and unaffected individual Bln1020) in the centromeric region. These findings narrow the locus by 2 cM from AFMA205XD5-D1S236 [Boon, 1999 No 811] to AFMB337XE1-D1S236, a region of about 3 cM (on the basis of the Whitehead/MIT physical map). Comparison of the haplotypes linked to the condition in the 12 families revealed two distinct haplotypes, A and B, shared by seven families (Bl, Bt, Sh, F, T, Bln, Sch), and by four families (Al, Ba, Del, Ad), respectively ( Figure 2) . Family Lml had a unique haplotype.
Statistical significance of the apparent linkage disequilibrium was assessed using the chi-square independence test. The frequency bias is significant (P < 0.01) for seven out of the nine markers in the core of the first haplotype (between D1S2804 and D1S2849, Figure 2, top) . This supports the hypothesis of a founder effect for this haplotype, and allows us to refine the locus further by inferring ancestral recombinations. In contrast, alleles of the second haplotype do not show statistically significant enrichment from the general population, and thus the second haplotype is probably due to co-occurrence of frequent alleles by chance (Figure 2,  bottom) . Thus, based on apparent ancestral crossovers in family T for the first haplotype, the VMGLOM locus can be delineated between marker 33CA1 and marker D1S2779. These two markers, and all intervening markers, have been localised on the same non-chimeric 1.48 Mbp YAC 957D9 (Whitehead/MIT database). 6 In this 1.48 Mbp VMGLOM region between 33CA1 and D1S2779, 13 PACs with unfinished sequences were identified as they contained at least one of the markers in the interval. Moreover, two PACs with finished sequences were also identified as belonging to the same PAC contig. On the basis of the Entrez Genome Map Viewer, most of the region appears to be covered by unfinished sequences, although there are two gaps. The ordering of the markers is consistent with our data. 6 In addition to putative genes and EST clusters, nine known or highly similar to known genes were identified in the region using sequence similarity searches. Known genes are EVI5 (ecotropic viral integration site 5), FAP48 (FKBP-associated protein), GFI1 (growth factor-independent 1) and RPL5 (ribosomal protein L5). The five other genes are highly similar ( > 90% identity) to ACTG1 (actin, gamma 1), AIF1 (allograft inflammatory factor 1), BTK (Bruton agammaglobulinemia tyrosine kinase), HMG4 (highmobility group protein 4) and RPL29 (ribosomal protein L29).
Discussion
In this study, we described seven new families with inherited cutaneous venous malformations with glomus cells that showed linkage to the VMGLOM locus on chromosome 1p21-p22. By combining the linkage data from these families with our previous data, the maximum two-point lod score was 18.41 (marker D1S188, θ = 0.0). The disease showed autosomal dominant inheritance pattern with high penetrance. Four young children were unaffected carriers. This non-penetrance was expected since it has been shown that the onset of the disease can be pubertal. 5 In addition, unaffected individual Del5, with an affected son, had inherited the haplotype associated with the condition in her family and is thus likely to be a carrier. Individual Bln104, on the contrary, had not inherited the haplotype linked with the disorder in his family, and thus his daughter, Bln1040, who has a single small ventral lesion, is probably a phenocopy. This underscores the uncertainty of clinical diagnosis of single small cutaneous lesions in genetic studies of vascular anomalies. Taken together, our data suggest that the VMGLOM locus contains the major gene for venous malformations with glomus cells.
Haplotype sharing in the VMGLOM locus A Irrthum et al y Haplotypic analysis revealed recombinative events in affected individuals, narrowing the region from 5-6 cM to 3 cM. Furthermore, in a subset of the families, we discovered a haplotype that is significantly associated with the disease, underlining the existence of a founder effect. This linkage disequilibrium allowed us to further diminish the locus by inferring ancestral crossovers to the region between markers 33CA1 and D1S2779. These markers are contained in a single 1.48 Mbp YAC, and thus this finding constitutes an important step towards positional cloning of the VMGLOM gene. Naturally, we cannot rule out the possibility that the apparent crossovers in markers 33CA1 and D1S1170 in family T are actually the consequence of marker mutations, as such mutations were observed inside the core of the first haplotype for markers D1S424, D1S406, 50CA1 and 75CA1 (Figure 2, top) . Taking this possibility into consideration, a very conservative analysis of the data delineates the locus between markers D1S188 and D1S2779.
Delineation of the region for the VMGLOM gene between markers 33CA1 and D1S2779 confirms our previous exclusion of several genes localised to the initial VMGLOM locus, either on the basis of mutation screening, for DR1 (depression of transcription 1), TFA (tissue factor) and TGRBR3 (transforming growth factor-receptor, type 3), or on the basis of function, for ABCR (ATP-binding-cassette transporter) and GLCLR (γ-glutamylcysteine synthetase). 5 Thanks to the human genome draft sequence, the VMGLOM region now contains nine genes of known or highly similar to known function. However, it is difficult to highlight the best candidate gene or to formally exclude others on the basis of current knowledge. Identification of the VMGLOM gene will probably enhance understanding of the etiopathogenesis of venous malformations, with and without glomus cells. As mutations in tyrosine-kinase receptors and other signalling molecules important for angiogenesis and vasculogenesis are the causes for vascular dysmorphogenesis in man and genetically engineered mice, it will be of great interest to know if the VMGLOM gene is related to these pathways, and in particular, to TIE2/TEK signalling.
